These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2868983)
1. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables]. Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology. Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473 [TBL] [Abstract][Full Text] [Related]
3. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology. Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563 [No Abstract] [Full Text] [Related]
4. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables. Albus M; Naber D; Müller-Spahn F; Douillet P; Reinertshofer T; Ackenheil M Biol Psychiatry; 1985 Oct; 20(10):1082-9. PubMed ID: 2864087 [TBL] [Abstract][Full Text] [Related]
5. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment]. Wolf MA; Bailly L; Diener JM; Martinet JP; Peretti S; Garneau Y Encephale; 1991; 17(4):255-61. PubMed ID: 1683626 [TBL] [Abstract][Full Text] [Related]
6. Lateral ventricular size, psychopathology, and medication response in the psychoses. Luchins DJ; Lewine RR; Meltzer HY Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730 [TBL] [Abstract][Full Text] [Related]
7. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients. Faraone SV; Brown WA; Laughren TP J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs. Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902 [No Abstract] [Full Text] [Related]
9. Suspension of neuroleptic therapy in acute schizophrenia. Kuhs H; Eikelmann B Pharmacopsychiatry; 1988 Jul; 21(4):197-202. PubMed ID: 2905064 [TBL] [Abstract][Full Text] [Related]
10. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology. Naber D; Ackenheil M; Laakmann G Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792 [TBL] [Abstract][Full Text] [Related]
11. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. Meltzer HY; Sommers AA; Luchins DJ J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856 [TBL] [Abstract][Full Text] [Related]
13. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse]. Woggon B; Bickel P; Schnyder B Int Pharmacopsychiatry; 1979; 14(5):278-93. PubMed ID: 43849 [TBL] [Abstract][Full Text] [Related]
14. [Incidence of the deficit form in refractory schizophrenia]. Samuelian JC Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037 [TBL] [Abstract][Full Text] [Related]
15. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient. Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883 [TBL] [Abstract][Full Text] [Related]
16. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients]. Bralet MC; Yon V; Loas G; Noisette C Encephale; 2000; 26(6):32-41. PubMed ID: 11217537 [TBL] [Abstract][Full Text] [Related]
17. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia. Yamagami S; Soejima K Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687 [TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients. Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889 [TBL] [Abstract][Full Text] [Related]
19. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094 [TBL] [Abstract][Full Text] [Related]